Growth vs Value Investing in Australia: Which Strategy Wins in 2026?

Last reviewed: May 2026

Here's a question that gets Australian investors worked up: should we be chasing growth, or sticking with the reliable dividend yields of our big banks and miners?

The answer everyone gives you is: "Both." But frankly, that's too easy. We think it's worth understanding what each strategy actually is, why the ASX tilts so heavily one way, and what the current rate environment means for your portfolio right now.

How do growth and value investing actually differ?

Growth investing is straightforward in theory. You buy companies that are expanding earnings faster than the market average. You're betting on accelerating sales, expanding margins, or new market opportunities. You accept that these companies rarely pay dividends because their cash is reinvested to fuel that growth.

Value investing is the opposite. You hunt for companies trading below their intrinsic worth. These are often mature businesses with steady cash flows, established market positions, and attractive dividend yields. You're buying a dollar for 70 cents.

The tension between them is real. Growth stocks can look expensive on traditional metrics because investors are pricing in future earnings. Value stocks can look cheap because everyone's written them off, or because they're genuinely mature businesses with limited upside. And this matters because which one you choose affects your returns, your volatility, and how you sleep at night.

Why is the ASX rigged for value?

Here's the thing about the Australian sharemarket: it's structurally a value investor's playground.

Look at the ASX 200. The biggest stocks are banks (Commonwealth, Westpac, NAB, ANZ), miners (BHP, Rio Tinto), and diversified industrials. These are mature, cash-generative, dividend-paying businesses. The ASX doesn't have a cohort of high-growth tech companies like NASDAQ does. There's no Amazon, no Microsoft, no Tesla on our market. We have some tech-adjacent names like WiseTech Global and Xero, but they're the exception, not the rule.

This structure is why value investing has historically won on the ASX over long periods. Franking credits don't hurt either. A 4% dividend yield on a bank stock becomes 5.7% when you factor in the dividend tax offset for many Australian taxpayers. That's a powerful incentive to own mature, dividend-paying stocks.

But structure isn't destiny. And this is where most investors get stuck.

How do rate environments change the game?

The relationship between interest rates and growth vs value stocks is almost mechanical.

When rates are high, discount rates rise. A dollar in earnings five years from now is worth less today. Growth stocks get hammered because most of their value comes from those distant future cash flows. Value stocks, by contrast, generate cash today, and a high interest rate makes that immediate cash more attractive. Simple as that.

But when rates fall, as they have started to in 2024-2026, the maths flips. Future earnings become more valuable. Growth stocks start to look reasonable again. This is why we've seen a rotation back into growth names as the RBA cut rates.

The question isn't which is "better." It's: which is more attractive given where rates are heading?

What's our take for 2026?

We don't think it's either/or. A diversified portfolio should include both value and growth. But in 2026, with rates stabilising at lower levels, we think growth is worth a tactical overweight.

Here's why. Interest rates in Australia are likely to remain elevated by historical standards, but the market has already priced in the worst. Inflation is cooling. The RBA is done hiking. The question now is when we'll see sustained rate cuts, not if. That window favours growth stocks.

But, and this matters, not all growth stocks are created equal. Chasing high-flying unprofitable startups is how you get hurt. We're talking about companies with real revenue growth, improving unit economics, and credible paths to sustained profitability.

On the ASX, that might look like:

WiseTech Global: Recurring revenue model, dominant market position, expanding into adjacent markets. Real growth, real moats.

Healthcare compounders: Companies riding Australia's ageing demographic, pathology, imaging, aged care operators with scale.

Technology-adjacent industrials: Businesses using software to automate or improve traditional industries. Often undervalued because they don't look like "tech."

Alongside these, keep your core holdings in quality value names. Commonwealth Bank, Woolworths, or even a defensive play like Brambles all provide stability and cash flow. The blend matters.

What's the real edge? Conviction over category

Here's what we've learned after years of doing this: the best investors don't get dogmatic about "growth" or "value." They get dogmatic about quality, competitive advantage, and valuation.

A growth stock that's cheap is value investing. A value stock with hidden growth catalysts is actually a growth opportunity. The labels matter less than the thinking behind them.

If you're not sure whether your portfolio has the right balance, or whether you're chasing the right names, we'd suggest stress-testing your holdings. Have you bought them because they fit a category, or because you genuinely understand why they'll compound wealth over the next 5-10 years?

That's the question that separates the amateurs from the pros.

A practical framework: how we think about style in 2026

Picking a side in the growth vs value debate can feel like a philosophical argument. In practice, the most successful Australian investors we know don't commit rigidly to one style. They commit to quality first, and then let valuation determine the category.

Here's the framework we use internally:

Step 1: Start with quality

Before asking "growth or value?" ask: "Is this a quality business?" A quality business has sustainable competitive advantage, generates returns on invested capital above its cost of capital, and is run by management with skin in the game. This filter eliminates most of the ASX immediately, many companies are mediocre businesses trading at mediocre valuations, and neither label applies usefully.

Step 2: Let valuation determine the entry

A quality business becomes a growth investment when its valuation implies the market is pricing in substantial future earnings expansion. It becomes a value investment when the market has discounted those same earnings excessively. The same company can flip between categories depending on its price.

WiseTech Global at 60x earnings is a growth bet. WiseTech at 25x earnings is a value buy within a growth company. The business is identical; the investment thesis changes.

Step 3: Size appropriately for the uncertainty

Growth positions, where you're relying on future earnings materialising, carry more uncertainty than value positions anchored to current earnings. That means growth positions should generally be smaller as a percentage of the portfolio than value positions, unless your conviction is unusually high and you've done the fundamental work to support it.

Portfolio Segment	Allocation	Style
Core holdings (banks, insurers, staples, industrials)	50-55%	Quality value
Growth positions (healthcare, software, clean energy)	25-30%	Quality growth
Cash / fixed income (dry powder for opportunities)	15-20%	Defensive

This isn't a binary choice. It's a portfolio.

What should you do now?

First, audit your portfolio. Count how many holdings are pure dividend plays vs. companies with real growth engines. If it's 80/20 income, that's fine, but you should know that by choice, not by accident.

Second, don't try to time the cycle. Buy quality when you can afford it, hold it, and let compounding work. A blend of 60-70% quality value and 30-40% growth makes sense for most Australian investors right now.

Third, get help understanding what you own. If you want to sense-check your portfolio against what the market is pricing, or identify which ASX names offer genuine growth at a reasonable price, join us for a webinar or check our research.

Frequently Asked Questions